Guangji Pharmaceutical (Mengzhou) Co. Ltd. announced that it will received CNY 180,000,000 in an equity round of funding on August 5, 2021. The transaction will include particpation from returning investor Hubei Guangji Pharmaceutical Co., Ltd. The transaction has been approved at the 5th Extraordinary Meeting of the 10th Directorate and the 5th Extraordinary Meeting of the 10th Supervisory Board of the investor.